2020年

Nishimura MF, Igawa T, Gion Y, Tomita S, Inoue D, Izumozaki A, Ubara Y, Nishimura Y, Yoshino T, Sato Y. Pulmonary manifestations of plasma cell type idiopathic multicentric Castleman disease: a clinicopathological study in comparison with IgG4-related disease. J Pers Med. 2020: 10, 269; doi:10.3390/jpm10040269.

 

Satou A, Tabata T, Suzuki Y, Sato Y, Tahara I, Mochizuki K, Oishi N, Takahara T, Yoshino T, Tsuzuki T, Nakamura S. Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases. Virchows Arch. 2020 Nov 9. doi: 10.1007/s00428-020-02967-6.

 

Tachibana T, Sasaki T, Wani Y, Komatsubara Y, Kuroda K, Naoi Y, Gion Y, Orita Y, Nishizaki K, Sato Y. Methotrexate-associated lymphoproliferative disorders mimicking granulomatosis with polyangiitis: a radiological diagnostic challenge. Ear Nose Throat J. 2020 Nov 6;145561320970685. doi: 10.1177/0145561320970685.

 

Tachibana T, Orita Y, Wani Y, Komatsubara Y, Kuroda K, Naoi Y, Gion Y, Makino T, Nishizaki K, Sato Y. Application of lip biopsy for the histological diagnosis of immunoglobulin G4-related disease. Ear Nose Throat J. 2020 Nov 4:145561320971932. doi: 10.1177/0145561320971932.

 

Kawatsuki A, Igawa T, Urata T, Tanaka T, Sato Y, Yoshino T. Deletion of BART miRNA-encoding cluster in Epstein-Barr virus DNA in classic Hodgkin lymphoma. Pathol Int. 2020 Sep 21. doi: 10.1111/pin.13022.

 

Kaji D, Ota Y, Sato Y, Nagafuji K, Ueda Y, Okamoto M, Terasaki Y, Tsuyama N, Matsue K, Kinoshita T, Yamamoto G, Taniguchi S, Chiba S, Ohshima K, Izutsu K. Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis. Blood Adv. 2020 Sep 22;4(18):4442-4450. doi: 10.1182/bloodadvances.2020002293.

 

Fajgenbaum DC, Wu D, Goodman A, Wong R, Chadburn A, Nasta S, Srkalovic G, Mukherjee S, Leitch H, Jayanthan R, Ferrero S, Sato Y, Schey S, Dispenzieri A, Oksenhendler E, Zinzani PL, Lechowicz MJ, Hoffmann C, Pemmaraju N, Bagg A, Fossa A, Lim MS, van Rhee F. Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease. Am J Hematol. 2020 Sep 7. doi: 10.1002/ajh.25992.

 

Saiki Y, Gion Y, Nishikori A, Norimatsu Y, Sato Y. Comparison of the hybrid Capture II method with a PCR-based screening method using a carboxyfluorescein-labeled primer for detecting human papillomavirus in cervicovaginal liquid-based cytology. J Mol Pathol. 2020, 1, 9–18; doi:10.3390/jmp1010003

 

Yu L, Shi M, Cai QQ, Strati P, Hagemeister F, Zhai QL, Li L, Fan X, Li J, Sun R, Zhang S, Yang H, Wang Z, Qian W, Iwaki N, Sato Y, Zhang L, Li J, Oksenhendler E, Xu-Monette ZY, Young KH. A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study. Oncologist. 2020 Aug 27. doi: 10.1634/theoncologist.2019-0986.

 

Sumii Y, Asada N, Sato Y, Ohshima KI, Makita M, Yoshimoto Y, Sogabe Y, Imajo K, Meguri Y, Ennishi D, Nishimori H, Fujii N, Matsuoka KI, Yoshino T, Maeda Y. Treatment outcomes of IgG4-producing marginal zone B-cell lymphoma: a retrospective case series. Int J Hematol. 2020 Aug 12. doi: 10.1007/s12185-020-02968-w.

 

Kawano M, Hara S, Yachie A, Sato Y, Fajgenbaum DC. HHV-8-negative multicentric Castleman disease patients with serological, histopathological and imaging features of IgG4-related disease. Reumatology (Oxford). 2020, Aug 9. doi:10.1093/rheumatology/keaa362

 

Akisada N, Nishimoto K, Takao S, Gion Y, Marunaka H, Tachibana T, Makino T, Miki K, Akagi Y, Tsumura M, Toji T, Yoshino T, Nishizaki K, Orita Y, Sato Y. PD-L1 expression in tongue squamous cell carcinoma. Med Mol Morphol. 2020 Jul 22. doi: 10.1007/s00795-020-00261-7.

 

Sakatani A, Igawa T, Okatani T, Fujihara M, Asaoku H, Sato Y, Yoshino T. Clinicopathological significance of CD79a expression in classic Hodgkin lymphoma. J Clin Exp Hematop. 2020 Jul 8. doi: 10.3960/jslrt.20010.

 

Ikeda T, Gion Y, Sakamoto M, Tachibana T, Nishikori A, Nishimura MF, Yoshino T, Sato Y. Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer. Mod Pathol. 2020 Jun 19. doi: 10.1038/s41379-020-0599-8. Online ahead of print.

 

Komatsubara Y, Tachibana T, Orita Y, Makino T, Kuroda K, Naoi Y, Kataoka Y, Sato Y, Kariya S, Nishizaki K. Clinical characteristics of subglottic cancer: emphasis on therapeutic management strategies for stage II subglottic cancer. Acta Otolaryngol. 2020 Jun 3:1-6. doi: 10.1080/00016489.2020.1767303.

 

Makino T, Tachibana T, Kariya S, Matsui Y, Matsuzaki H, Fujimoto S, Orita Y, Katsui K, Hiraki T, Sato Y, Kanazawa S, Nishizaki K. Pathological Evaluation of Radiotherapy and Concomitant Intraarterial Cisplatin for Maxillary Sinus Cancer. Auris Nasus Larynx. 2020 Apr 22;S0385-8146(20)30085-7. doi: 10.1016/j.anl.2020.04.004.

 

Satou A, Notohara K, Zen Y, Nakamura S, Yoshino T, Okazaki K, Sato Y. Clinicopathological differential diagnosis of IgG4-related disease: A historical overview and a proposal of the criteria for excluding mimickers of IgG4-related disease. Pathol Int. 2020 Apr 20. doi: 10.1111/pin.12932.

 

Yoshino T, Tanaka T, Sato Y. Differential diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma and other indolent lymphomas, including mantle cell lymphoma. J Clin Exp Hematop. 2020 Apr 3. doi: 10.3960/jslrt.19041.

 

Gion Y, Okano M, Koyama T, Oura T, Nishikori A, Orita Y, Tachibana T, Marunaka H, Makino T, Nishizaki K, Sato Y. Clinical significance of cytoplasmic IgE-positive mast cells in eosinophilic chronic rhinosinusitis. Int J Mol Sci. 2020 Mar 7; 21(5). pii: E1843. doi: 10.3390/ijms21051843.

 

Han Y, Igawa T, Ogino K, Nishikori A, Gion Y, Yoshino T, Sato Y. Hemosiderin deposition in lymph nodes of patients with plasma cell-type Castleman disease. J Clin Exp Hematop. 2020 Feb 8. doi: 10.3960/jslrt.19037.

 

Oka A, Ninomiya T, Fujiwara T, Takao S, Sato Y, Gion Y, Minoura A, Haruna SI, Yoshida N, Sakuma Y, Izuhara K, Ono J, Taniguchi M, Haruna T, Higaki T, Kariya S, Koyama T, Takabayashi T, Imoto Y, Sakashita M, Kidoguchi M, Nishizaki K, Fujieda S, Okano M. Serum IgG4 as a biomarker reflecting pathophysiology and post-operative recurrence in chronic rhinosinusitis. Allergol Int. 2020 Jan 14. pii: S1323-8930(19)30201-1. doi: 10.1016/j.alit.2019.12.004.

 

Omote R, Gion Y, Omote S, Tari A, Tanaka T, Nishikori A, Yoshino T, Sato Y. Clinicopathologic analysis of gastric mucosa-associated lymphoid tissue lymphoma with or without c-Met expression. Med Mol Morphol. 2020 Jan 2. doi: 10.1007/s00795-019-00241-6.

 

Makino T, Orita Y, Gion Y, Tachibana T, Takao S, Marunaka H, Miki K, Akisada N, Akagi Y, Yoshino T, Nishizaki K, Sato Y. MACC1 expression is an indicator of recurrence in early-stage glottic cancer. Jpn J Clin Oncol. 2020 Jan 2. doi: 10.1093/jjco/hyz206.

 

Wallace ZS, Naden RP, Chari S, Choi HK, Della-Torre E, Dicaire JF, Hart PA, Inoue D, Kawano M, Khosroshahi A, Lanzillotta M, Okazaki K, Perugino CA, Sharma A, Saeki T, Schleinitz N, Takahashi N, Umehara H, Zen Y, Stone JH, Akamizu T, Akiyama M, Barra L, Bateman A, Blockmans D, Brito-Zeron P, Campochiaro C, Carruthers M, Chiba T, Cornell L, Culver E, Darabian S, Deshpande V, Dong L, Ebbo M, Fernández-Codina A, Ferry JA, Fragkoulis G, Frost F, Frulloni L, Hernandez-Molina G, Ji H, Keat K, Kamisawa T, Kawa S, Kobayashi H, Kodama Y, Kubo S, Kubota K, Leng H, Lerch M, Liu Y, Liu Z, Löhr M, Martin-Nares E, Martinez-Valle F, Marvisi C, Masaki Y, Matsui S, Mizushima I, Nakamura S, Nordeide J, Notohara K, Paira S, Popovic J, Ramos-Casals M, Rosenbaum J, Ryu J, Sato Y, Sekiguchi H, Sokol EV, Stone JR, Sun W, Takahashi H, Takahira M, Tanaka Y, Vaglio A, Villamil A, Wada Y, Webster G, Yamada K, Yamamoto M, Yi J, Yi Y, Zamboni G, Zhang W. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 Jan;79(1):77-87. doi: 10.1136/annrheumdis-2019-216561.